Infliximab for very early-onset inflammatory bowel disease: A tertiary center experience in Japan.

Ichiro TakeuchiYoichiro KaburakiKatsuhiro AraiHirotaka ShimizuYuri HiranoSatoru NagataToshiaki Shimizu

Published in: Journal of gastroenterology and hepatology (2019)

Infliximab appeared useful for children with VEO-IBD. Children with NUC-PD and NUC-NPD responded better with less infusion reaction compared with that with UCT.

Keyphrases

early onset
ulcerative colitis
young adults
late onset
low dose